MedPath

The implications of discussing uncertainty in cancer genetic counseling about multigene panel testing for (analogue) patients* cognitive and affective outcomes.

Completed
Conditions
Hereditary cancer
oncological predisposition
10083624
Registration Number
NL-OMON49684
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
222
Inclusion Criteria

Adults who have visited one of the participating genetic centers and having
received genetic counseling for hereditary cancer.

Exclusion Criteria

Children, and adults having received genetic counseling for possible hereditary
predispostition for other diseases than cancer. Being either cancer patient
themselves or a relative of a cancer patient.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Degree of uncertainty</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Degree of anxiety, degree of control, satisfaction, hope, trust, trust in<br /><br>understanding, information recall and decision-making.</p><br>
© Copyright 2025. All Rights Reserved by MedPath